JP2001519181A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519181A5
JP2001519181A5 JP2000515920A JP2000515920A JP2001519181A5 JP 2001519181 A5 JP2001519181 A5 JP 2001519181A5 JP 2000515920 A JP2000515920 A JP 2000515920A JP 2000515920 A JP2000515920 A JP 2000515920A JP 2001519181 A5 JP2001519181 A5 JP 2001519181A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000515920A
Other languages
Japanese (ja)
Other versions
JP2001519181A (ja
Filing date
Publication date
Priority claimed from US09/021,298 external-priority patent/US6156317A/en
Application filed filed Critical
Publication of JP2001519181A publication Critical patent/JP2001519181A/ja
Publication of JP2001519181A5 publication Critical patent/JP2001519181A5/ja
Pending legal-status Critical Current

Links

JP2000515920A 1997-10-14 1998-05-11 ヒトサイトメガロウィルスの免疫反応性ペプチドctlエピトープ Pending JP2001519181A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95006497A 1997-10-14 1997-10-14
US08/950,064 1997-10-14
US09/021,298 US6156317A (en) 1996-11-12 1998-02-10 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US09/021,298 1998-02-10
PCT/US1998/009652 WO1999019349A1 (en) 1997-10-14 1998-05-11 Immuno-reactive peptide ctl epitopes of human cytomegalovirus

Publications (2)

Publication Number Publication Date
JP2001519181A JP2001519181A (ja) 2001-10-23
JP2001519181A5 true JP2001519181A5 (enExample) 2005-12-22

Family

ID=26694530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000515920A Pending JP2001519181A (ja) 1997-10-14 1998-05-11 ヒトサイトメガロウィルスの免疫反応性ペプチドctlエピトープ

Country Status (8)

Country Link
US (1) US6156317A (enExample)
EP (1) EP1023319B1 (enExample)
JP (1) JP2001519181A (enExample)
AT (1) ATE276270T1 (enExample)
AU (1) AU7481498A (enExample)
CA (1) CA2308118A1 (enExample)
DE (1) DE69826304T2 (enExample)
WO (1) WO1999019349A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
EP1181313B1 (de) 1999-06-04 2011-02-09 Florian Kern Peptide zur vakzinierung gegen das humane cmv
US6632435B1 (en) 1999-10-20 2003-10-14 City Of Hope CTL epitope analogs
US6835383B2 (en) * 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
EP1612217A3 (en) * 2000-03-27 2006-01-18 City of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
AU2002214624A1 (en) 2000-10-20 2002-05-06 City Of Hope Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE10225139A1 (de) * 2002-05-29 2004-02-26 Immatics Biotechnologies Gmbh Verfahren zur Identifizierung von immunreaktiven Peptiden
US20040101534A1 (en) * 2002-06-25 2004-05-27 Diamond Don J. Adjuvant-free peptide vaccine
WO2004058166A2 (en) * 2002-12-23 2004-07-15 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
WO2004093905A1 (en) * 2003-04-16 2004-11-04 City Of Hope Human cytomegalovirus antigens expressed in mva and methods of use
US20080138354A1 (en) * 2006-07-21 2008-06-12 City Of Hope Cytomegalovirus vaccine
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
EP2167537A2 (en) * 2007-07-03 2010-03-31 Dako Denmark A/S Compiled methods for analysing and sorting samples
EP2197908A2 (en) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
CA2728739C (en) * 2008-06-20 2017-07-11 Duke University Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2016209816A1 (en) 2015-06-26 2016-12-29 Memorial Sloan Kettering Cancer Center Methods of treating cmv retinitis by t cell therapy
CA3002922A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Human cytomegalovirus vaccine
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
EP3898666A2 (en) 2018-12-17 2021-10-27 Immudex ApS Panel comprising borrelia mhc multimers
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11857622B2 (en) 2020-06-21 2024-01-02 Pfizer Inc. Human cytomegalovirus GB polypeptide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075213A (en) * 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
WO1994000150A1 (en) * 1992-06-25 1994-01-06 City Of Hope Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides
US5470730A (en) * 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes
CA2092548A1 (en) * 1990-09-28 1992-03-29 Philip D. Greenberg Method for producing th-independent cytotoxic t lymphocytes
US5405940A (en) * 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US5827642A (en) * 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
CA2271784A1 (en) * 1996-11-12 1998-05-22 City Of Hope Immuno-reactive peptide ctl epitopes of human cytomegalovirus

Similar Documents

Publication Publication Date Title
BE2014C048I2 (enExample)
BRPI9917862A2 (enExample)
JP2001519181A5 (enExample)
BY4408C1 (enExample)
BY6371C1 (enExample)
CL1998003164A1 (enExample)
CN3073190S (enExample)
CN3073425S (enExample)
CN3073550S (enExample)
CN3073771S (enExample)
CN3074052S (enExample)
CN3074054S (enExample)
CN3074474S (enExample)
CN3074693S (enExample)
CN3074906S (enExample)
CN3074964S (enExample)
CN3074993S (enExample)
CN3075068S (enExample)
CN3075297S (enExample)
CN3075591S (enExample)
CN3075658S (enExample)
CN3076976S (enExample)
CN3077504S (enExample)
CN3077688S (enExample)
CN3077894S (enExample)